Posted in M&A / Deals Lilly beefs up neuroscience pipeline with $6.3B Centessa buyout March 31, 2026 BioPharma Dive The deal secures two sleep disorder drugs that would fill a hole in the company s portfolio and intensify a competition with Takeda and Eisai. M&A / DealsNeuroscienceRead full story